MedPath

Comparison of rates of extravasation injuries and phlebitis between fixed duration use of peripheral intravenous cannula and standard practice in newborns infants.

Completed
Conditions
Extravasation injuries associated with peripheral intravenous cannula use in neonates
Phlebitis associated with peripheral intravenous cannula use in neonates
Public Health - Health service research
Inflammatory and Immune System - Other inflammatory or immune system disorders
Registration Number
ACTRN12615000827538
Lead Sponsor
Dr Atul Malhotra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
104
Inclusion Criteria

Newborns who are born at least 32 weeks of gestation admitted into Neonatal Intensive Care Unit and Special Care Nursery who requires a peripheral intravenous cannula for treatment and management.

Exclusion Criteria

Babies who have concurrent use of intravenous access other than peripheral intravenous cannula

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rates of extravasation injury. This will be assessed by the presence of signs of extravasation injury identified by nursing and medical staff. These signs include: distress with flushing, swelling at site, skin blanching, delayed capillary refill time, blistering of skin, absent peripheral pulse. Nursing staff will be required to fill out an observation log to indicate if these signs occur during their shift. If signs occur, this will prompt the need for medical review to assess for need of PIVC re-site.[Participants will be monitored until the peripheral intravenous cannula is no longer required for that episode of intravenous therapy use. Duration of monitoring therefore depends on individual participant's situation. Rate of infiltration injury will be assessed at the end of study]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath